Multiple Myeloma
|
0.310 |
Biomarker
|
disease |
BEFREE |
ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
|
16044163 |
2005 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
As such, NUAK1 may play key roles in multiple diseases ranging from neurodegeneration to diabetes and metastatic cancer.
|
29106388 |
2018 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The aim of this study is to determine the roles of NUAK1 and miR-204 in the drug resistance and metastasis of liver cancer and to reveal their relationship.
|
30807203 |
2019 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The aim of this study is to determine the roles of NUAK1 (a downstream of Akt) and miR-204 in the invasiveness and metastasis of NSCLC and to reveal the correlation between NUAK1 and miR-204.
|
25412236 |
2014 |
Neoplasm Metastasis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Retraction: Wang, L., Ma, X., Yan, L., Wang, T., Wen, J. and Mi, G., LncRNA SNHG1 negatively regulates miR-145a-5p to enhance NUAK1 expression and promote cancer cell metastasis and invasion in nasopharyngeal carcinoma. J Cell Physiol. Accepted Author Manuscript. doi:10.1002/jcp.26340.
|
29215719 |
2017 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
We identified ARK5 (AMPK-Related Protein Kinase 5, also referred to as NUAK Family Kinase 1) as a novel metabolic target present in all species, and independent analyses confirmed glucose metabolism as the most significantly aberrant cellular signaling pathway in a model system for highly metastatic tumors.
|
29100308 |
2017 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Interestingly, only the ARK5-overexpressing PANC-1 cell line (P/ARK) tumor showed invasion and metastasis in nude mice, although Akt was activated in tumors derived from both P/ARK and its parental cell line.
|
15060171 |
2004 |
Neoplasm Metastasis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
The elevated ARK5 expression was closely associated with cancer metastasis and patient survival, and it seemed to function in GC cells migration and invasion via EMT alteration, together with the alteration of the mTOR/p70S6k signals, Slug and SIP1, thus providing a potential therapeutic target for GC.
|
28662499 |
2017 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Furthermore, ARK5 is found to play a role in ICC metastasis and regulating EMT.
|
31360102 |
2019 |
Neoplasm Metastasis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Based on these observations, it is suggested that ARK5 expression is involved in cancer invasion and metastasis.
|
15354411 |
2004 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Inhibition of ARK5 was able to significantly reduce the ability HCC cells to invade and metastasize.
|
29434843 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
We found that NUAK1 was increased in the tumor of primary liver cancer.
|
30807203 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
ARK5 is a member of the human AMP-activated protein kinase (AMPK) family which is implicated in tumor survival and progression.
|
28469776 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Our results showed that the high expression of ARK5 in HCC was related to tumor size (p=0.005), histological differentiation (p=0.047), and tumor stage (p=0.005).
|
23516026 |
2013 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The expression of NUAK1 was also strongly associated with OS (p = 0.044) and DFS (p = 0.007) in patients of late stage tumour (UICC3-5), but not in patients of early stage tumour (UICC1-2).
|
30121842 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The tumorigenicity and spontaneously metastatic capability regulated by ARK5 were determined using an orthotopic xenograft tumor model.
|
22105900 |
2012 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
We report that a novel AMPK catalytic subunit family member, ARK5, plays a key role in tumor malignancy downstream of Akt.
|
15060171 |
2004 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our data point to a novel role for calcium in supporting tumour cell viability and clarify the synthetic lethal interaction between NUAK1 and MYC.
|
29106388 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
AMPK-related kinase 5 (ARK5) is a member of the human AMP-activated protein kinase (AMPK) family, which is associated with increased tumor survival and drug resistance in many cancers.
|
30662653 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
These findings have highlighted a novel role for NUAK1 in LKB1-related signaling pathways; NUAK1 can regulate cell proliferation and exert tumor suppression through direct interaction with p53.
|
21317932 |
2011 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The activation of ARK5 is triggered by Akt, and ARK5 induces tumor cell survival during nutrient starvation.
|
13679856 |
2003 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.
|
26255969 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Mechanistically, SNHG6 induced EMT of BC cells by upregulating the expression levels of Snail1/2 and regulated BC cell migration and invasion by tumor suppressive hsa-miR-125b and its target gene NUAK Family Kinase 1 (NUAK1).
|
30168179 |
2019 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Taken together, our results suggest that NUAK1 plays an important role in NSCLC cell migration and invasion.
|
23215946 |
2013 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
However, the role of ARK5 in invasion and metastasis of HCC cells remains unclear.
|
29434843 |
2018 |